ENSYSCE BIOSCIENCES, INC.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense
Operating Income $-959.2K
Operating Margin
Interest Expense
Pretax Income $2.7M
Income Tax Expense $553.9K
Net Income $2.1M
Net Margin
EPS (Basic) $-0.01
EPS (Diluted) $-0.01
Shares Outstanding (Basic) 120.8M 134.7M
Shares Outstanding (Diluted) 120.8M 134.7M
Dividends Per Share
← Newer Page 2 of 2 Older →